Literature DB >> 3304809

Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia.

L L Moldawer, M Georgieff, K Lundholm.   

Abstract

Soluble proteins synthesized and released by phagocytic cells may be responsible for the protein and energy wasting frequently observed during catabolic states, including cancer cachexia. This hypothesis is based upon the observation that many of the hosts's metabolic responses to infection, inflammation, accidental trauma and some forms of cancer are remarkably similar. Anorexia and degradation of skeletal and connective tissue protein, as well as increases in hepatic protein synthesis and energy expenditure, can all be reproduced by the administration of activated macrophage products. During inflammatory states, including active tumour growth, increased production of some cytokines, including interleukin 1 and tumour necrosis factor-alpha (cachectin), have been observed. If these monokines serve as metabolic inducers, then efforts to block therapeutically the actions of macrophage-secreted substances may play a role in slowing the progression of tissue-wasting associated with catabolic states, particularly due to malignant tumours.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3304809     DOI: 10.1111/j.1475-097x.1987.tb00169.x

Source DB:  PubMed          Journal:  Clin Physiol        ISSN: 0144-5979


  19 in total

1.  Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response.

Authors:  M Maes; R Verkerk; E Vandoolaeghe; F Van Hunsel; H Neels; A Wauters; P Demedts; S Scharpé
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

Review 2.  Nutrition and HIV infection in children.

Authors:  E E Mannick; J N Udall; M Kaiser; G Fuchs; R Suskind
Journal:  Indian J Pediatr       Date:  1996 Sep-Oct       Impact factor: 1.967

Review 3.  Why do anti-inflammatory therapies fail to improve insulin sensitivity?

Authors:  Zhan-guo Gao; Jian-ping Ye
Journal:  Acta Pharmacol Sin       Date:  2011-10-31       Impact factor: 6.150

4.  Modulation of endotoxin lethality in mice by hydrazine sulfate.

Authors:  R Silverstein; C A Christoffersen; D C Morrison
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

5.  Protein metabolism in the tumour-bearing mouse. Rates of protein synthesis in host tissues and in an Ehrlich ascites tumour at different stages in tumour growth.

Authors:  M N Lopes; P Black; A J Ashford; V M Pain
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

6.  Evidence for the involvement of interleukin 6 in experimental cancer cachexia.

Authors:  G Strassmann; M Fong; J S Kenney; C O Jacob
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

7.  Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.

Authors:  K J Tracey; S Morgello; B Koplin; T J Fahey; J Fox; A Aledo; K R Manogue; A Cerami
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 8.  Are cytokines possible mediators of cancer cachexia?

Authors:  Y Noguchi; T Yoshikawa; A Matsumoto; G Svaninger; J Gelin
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

9.  Weight loss in obese mice persistently infected with lymphocytic choriomeningitis virus is not associated with elevated tumor necrosis factor/cachectin activity in peritoneal macrophages.

Authors:  J L Lathey; M B Oldstone
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

10.  Characterization of a tumor necrosis factor-responsive element which down-regulates the human osteocalcin gene.

Authors:  Y P Li; P Stashenko
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.